𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer

✍ Scribed by S. NAGAO; K. FUJIWARA; R. OHISHI; Y. NAKANISHI; N. IWASA; M. SHIMIZU; T. GOTO; K. SHIMOYA

Book ID
109086396
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
78 KB
Volume
18
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
✍ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th

Consolidation hyperthermic intraperitone
Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer
✍ Jin Hwi Kim; Joon Mo Lee; Ki Sung Ryu; Yong Seok Lee; Yong Gyu Park; Soo Young H πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract ## Background We evaluated the efficacy and feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) using paclitaxel as consolidation therapy in patients with epithelial ovarian cancer. ## Methods Between November 1999 and January 2004, 18 patients with a negative second‐loo